News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
799,782 Results
Type
Article (60506)
Company Profile (539)
Press Release (738717)
Multimedia
Podcasts (182)
Webinars (29)
Section
Business (218902)
Career Advice (3362)
Deals (37815)
Drug Delivery (150)
Drug Development (87767)
Employer Resources (192)
FDA (17701)
Job Trends (16192)
News (373065)
Policy (36270)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2984)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (172)
Alliances (53865)
ALS (205)
Alzheimer's disease (1867)
Antibody-drug conjugate (ADC) (410)
Approvals (17943)
Artificial intelligence (675)
Autoimmune disease (245)
Automation (52)
Bankruptcy (387)
Best Places to Work (12385)
BIOSECURE Act (23)
Biosimilars (214)
Biotechnology (366)
Bladder cancer (187)
Brain cancer (72)
Breast cancer (727)
Cancer (5626)
Cardiovascular disease (494)
Career advice (2868)
Career pathing (45)
CAR-T (331)
CDC (68)
Celiac Disease (2)
Cell therapy (904)
Cervical cancer (42)
Clinical research (74995)
Collaboration (2070)
Company closure (7)
Compensation (1311)
Complete response letters (90)
COVID-19 (2969)
CRISPR (110)
C-suite (1048)
Cystic fibrosis (160)
Data (7242)
Decentralized trials (3)
Denatured (61)
Depression (176)
Dermatology (59)
Diabetes (589)
Diagnostics (7216)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (333)
Drug pricing (230)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (94812)
Editorial (70)
Employer branding (24)
Employer resources (168)
Events (130734)
Executive appointments (1099)
FDA (21244)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1726)
Gene editing (238)
Generative AI (62)
Gene therapy (750)
GLP-1 (1173)
Government (5313)
Grass and pollen (8)
Guidances (399)
Healthcare (20559)
HIV (79)
Huntington's disease (57)
IgA nephropathy (96)
Immunology and inflammation (321)
Immuno-oncology (91)
Indications (158)
Infectious disease (3310)
Inflammatory bowel disease (222)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (282)
Interviews (640)
IPO (17372)
IRA (61)
Job creations (4163)
Job search strategy (2324)
JPM (72)
Kidney cancer (19)
Labor market (96)
Layoffs (642)
Leadership (44)
Legal (8833)
Liver cancer (105)
Longevity (29)
Lung cancer (752)
Lymphoma (417)
Machine learning (54)
Management (64)
Manufacturing (984)
MASH (192)
Medical device (14758)
Medtech (14840)
Mergers & acquisitions (21622)
Metabolic disorders (1566)
mRNA (211)
Multiple sclerosis (180)
NASH (23)
Neurodegenerative disease (432)
Neuropsychiatric disorders (115)
Neuroscience (3378)
Neurotech (1)
NextGen: Class of 2026 (7382)
Non-profit (5018)
Now hiring (73)
Obesity (761)
Opinion (353)
Ovarian cancer (188)
Pain (248)
Pancreatic cancer (266)
Parkinson's disease (361)
Partnered (35)
Patents (575)
Patient recruitment (619)
Peanut (64)
People (63778)
Pharmaceutical (96)
Pharmacy benefit managers (36)
Phase 1 (23403)
Phase 2 (32881)
Phase 3 (24534)
Pipeline (7302)
Policy (363)
Postmarket research (2938)
Preclinical (10112)
Press Release (72)
Prostate cancer (290)
Psychedelics (61)
Radiopharmaceuticals (328)
Rare diseases (1113)
Real estate (6593)
Recruiting (78)
Regulatory (27383)
Reports (59)
Research institute (2708)
Resumes & cover letters (537)
Rett syndrome (33)
RNA editing (22)
RSV (94)
Schizophrenia (175)
Series A (290)
Series B (214)
Service/supplier (14)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (51)
Startups (4026)
State (2)
Stomach cancer (21)
Supply chain (125)
Tariffs (100)
The Weekly (118)
Vaccines (1195)
Venture capital (111)
Weight loss (512)
Women's health (113)
Worklife (23)
Date
Last 7 days (670)
Last 30 days (2555)
Last 365 days (31839)
2026 (8493)
2025 (32190)
2024 (37340)
2023 (42156)
2022 (53493)
2021 (58219)
2020 (56970)
2019 (50309)
2018 (38169)
2017 (35388)
2016 (35593)
2015 (41490)
2014 (35421)
2013 (30691)
2012 (32807)
2011 (33238)
2010 (31500)
Location
Africa (1030)
Alabama (96)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (45353)
Australia (7729)
California (12670)
Canada (3588)
China (1316)
Colorado (542)
Connecticut (549)
Delaware (374)
Europe (103567)
Florida (1903)
Georgia (414)
Hawaii (3)
Idaho (67)
Illinois (1048)
India (86)
Indiana (585)
Iowa (24)
Japan (504)
Kansas (136)
Kentucky (49)
Louisiana (41)
Maine (85)
Maryland (1541)
Massachusetts (9240)
Michigan (368)
Minnesota (709)
Mississippi (7)
Missouri (152)
Montana (37)
Nebraska (30)
Nevada (140)
New Hampshire (89)
New Jersey (3401)
New Mexico (33)
New York (3368)
North Carolina (1698)
North Dakota (10)
Northern California (6210)
Ohio (380)
Oklahoma (24)
Oregon (45)
Pennsylvania (2541)
Puerto Rico (27)
Rhode Island (52)
South America (1398)
South Carolina (78)
South Dakota (1)
Southern California (4963)
Tennessee (204)
Texas (2014)
United States (45404)
Utah (382)
Vermont (1)
Virginia (307)
Washington D.C. (84)
Washington State (1040)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
799,782 Results for "the sage group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
February 1, 2026
·
4 min read
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite these treatments.
February 27, 2026
·
6 min read
·
Heather McKenzie
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
After the FDA rejection of Zurzuvae in one type of depression and the triple failure of neuro asset dalzanemdor, Sage was searching for a path forward at the end of December 2024. Biogen CEO Chris Viehbacher spied a possible deal, but the smaller company wasn’t interested.
July 3, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
RevMedica Announces Abstract Highlighting Real-Time, Actionable Insight Technology Accepted at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting
March 13, 2026
·
2 min read
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
As of Apr. 22, Sage had 338 full-time employees, all of whom will be laid off effective Aug. 22. The layoffs were announced a few weeks after Maryland’s Supernus Pharmaceuticals acquired Sage for up to $795 million.
June 30, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer
July 29, 2025
·
11 min read
Press Releases
Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group
March 24, 2026
·
3 min read
Press Releases
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
January 8, 2026
·
4 min read
Business
Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin’s Late-Stage Development and Commercialization
Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) today announced an engagement with The Sage Group (www.sagehealthcare.com) to assist the company in exploring strategic partnerships, co-development and licensing agreements for tecarfarin.
December 12, 2023
·
7 min read
Press Releases
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
August 1, 2025
·
9 min read
1 of 79,979
Next
